CA-HYPERICE
4.4.2022 12:02:04 CEST | Business Wire | Press release
Hyperice , a global high-performance wellness brand, today introduced a new and improved version of its original, award-winning handheld massage gun, the Hypervolt Go. Leveling up and standing on its own within the percussive massage category, the newly redesigned, lightweight and versatile Hypervolt Go 2 is the most sophisticated portable percussion massager to hit the wellness market and is built to increase people’s range of motion with just a five minute treatment each day1 .
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220404005376/en/
The Hypervolt Go 2 adds to the company’s range of powerful percussion devices including the recently launched Hypervolt 2 and Hypervolt 2 Pro , all of which help everyday users and pro athletes alike massage away stress and muscle tension from the palm of their hand.
“For over 10 years, Hyperice has been relentlessly focused on developing innovative products to help people across the globe move and live better. The new Hypervolt Go 2 offers a unique combination of performance and portability for the wellness-minded consumer,” said Jim Huether, CEO of Hyperice. “Designed for the everyday go-getter, the Hypervolt Go 2 is a wellness essential - perfect for everyone who is moving at home or on the road and wants to be at their best everyday.”
“The Hypervolt Go 2 is the result of our 'design first’ approach to creating a product that looks as good as it feels. We wanted to design a product that people would want to take and use everywhere they go,” said Anthony Katz, Founder and President of Hyperice. “With this newest addition to the Hypervolt family, the Hypervolt Go 2 offers more choice, to more people, in more places than ever before.”
WELLNESS THAT MOVES WITH YOU
The new Hypervolt Go 2 has a sophisticated design that features minimalistic looks with an arctic-grey finish and feels great in your hand and on your body. It is built to last, with high-quality materials and intuitive ergonomics. The Hypervolt Go 2 is designed to move conveniently wherever users are headed and includes features such as:
- Patented QuietGlide® technology for near silent operation
- Improved airflow and ventilation
- New LED speed sensors and back button control
- New ergonomic handle
- Battery level LED band
- Three speeds of powerful percussion
Go behind the design of the Hypervolt Go 2.
Katz continued: “Our mission from the beginning, was to put a percussion device in as many hands as possible. To do that, we need to continue to design products that are accessible to the widest possible audience of users. We also know, with the world opening back up, people are constantly on the move, and space can oftentimes be limited, so the smaller you can make the device, the more places you can take it, the more you can use it. Hypervolt Go 2 represents the next step towards achieving that goal.”
“My current phase of my career is about longevity and maintaining a competitive advantage,” said Kelly Slater, 11-time World Surf League champion and Hyperice Athlete-Investor. “To be my best when I’m competing, I have to also feel great no matter where I am, which is why I never leave home without the Hypervolt Go 2. It’s the ultimate in portability, it’s dead silent and it comes in clutch whether I’m preparing for a major event or just managing everyday aches.”
The Hypervolt Go 2 retails for $199 (£199; €229) and is now available in North America and other select regions. For more information, visit hyperice.com . To purchase, please visit country-specific sites: Canada , France , Germany , Italy , Portugal , Spain , UK and the United States .
To learn more about the Hypervolt Go 2, visit hyperice.com .
INTRODUCING: THE GO COLLECTIVE
To amplify the ethos of the Go line, Hyperice has assembled a diverse collection of individuals within #TeamHyperice who represent different industries and backgrounds who are pushing the boundaries of what it means to ‘go get it.’ The Go Collective seeks to make a movement out of movement across the many dimensions of fitness, fashion, lifestyle, sports, travel, longevity, wellness, art, family, and more. Through expansive storytelling and involvement in community initiatives and events, Hyperice hopes the Go Collective will inspire individuals everywhere to prioritize their daily wellness.
Meet the inaugural Go Collective members:
- Robin Arzón, Head Instructor and VP of Fitness Programming at Peloton
- Tony Finau, PGA TOUR Golfer
- Adrianne Ho, Model and Founder of Sweat The Style & The Farmers Market Global
- Joe Holder, Nike Master Trainer and Founder of The Ocho System™
- Alix Klineman, Beach Volleyball Olympic Gold Medalist
- Kelly Slater, Professional Surfer
- Nigel Sylvester, Pro BMX Athlete and Content Creator
- Raven B. Varona (Ravie B), Professional Photographer
“I’m proud to be a member of Hyperice’s new Go Collective because it represents a community for people who show up everyday for themselves and for others,” said Robin Arzón, Head Instructor and VP of Fitness Programming at Peloton. “I believe there is transformative power in movement and as a mom, wife and athlete, being able to be at my best in all dimensions of my life is what motivates me to ‘go get it’. Hyperice’s suite of products, and the Hypervolt Go 2 in particular, are my go-to wellness tools that help me be at my best each and every day.”
“I take my role as a husband and father of five even more seriously than my career as a pro golfer. There’s no doubt staying healthy is a huge part of my commitment to performance, but more importantly, it’s critical to me that I’m the best version of myself whenever I’m spending valuable time with my family,” said Tony Finau, PGA TOUR player and Hyperice investor. “The Hypervolt Go 2 goes with me everywhere – on the course during competition, training and recovery, and when I’m traveling between tournaments – to ensure that I can push to the limits of my full potential for years to come.”
“When it comes to feeling your best, a major part of that is making sure to move and to move effectively everyday, and recovery is a critical component of a holistic approach to an individual’s overall wellness,” said Joe Holder, Nike Master Trainer and Founder of The Ocho System™. “As someone who gets the opportunity to help so many people unlock their personal version of wellness, the Hypervolt Go 2 is an incredible tool for anyone to utilize to help ensure they can come back day after day - ready to be anything but average.”
To join the Go Collective community, follow Hyperice on social - instagram.com/hyperice and twitter.com/hyperice and sign up for emails on hyperice.com to unlock exclusive content, special offers, access to events and more. Learn more at: hyperice.com/newsroom/go-collective
About Hyperice
Hyperice is a technology-driven company with a giant mission, to help everyone on Earth move and live better. For more than a decade, Hyperice has led a global movement at the confluence of recovery and wellness, specializing in percussion (Hypervolt line), dynamic air compression (Normatec line), vibration (Vyper and Hypersphere lines), thermal technology (Venom line), mind technology (Core by Hyperice) and contrast therapy (Hyperice X). Now, as a holistic high-performance wellness brand, Hyperice is designed for all - from the most elite athletes, leagues and teams to consumers everywhere looking to unlock the best version of themselves to help them do what they love, more. Recognized as one of Fast Company’s Most Innovative Companies, Hyperice has applied its technology and know-how to industries including fitness, hospitality, healthcare, massage, physical therapy, sports performance and workplace wellness on a global scale. Hyperice’s transformative acquisitions of Normatec, RecoverX and Core have helped to accelerate its innovation agenda as it enters its next stage of global growth. For more information, visit the newly redesigned hyperice.com .
1 Journal of Sports Science & Medicine 2020
View source version on businesswire.com: https://www.businesswire.com/news/home/20220404005376/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
International Human Rights Lawyer Jared Genser and Former White House Counsel Lanny J. Davis Join Legal and Advocacy Team Supporting Cambodian Businessman Yim Leak, Seiden Law LLP Announces18.9.2026 19:52:00 CEST | Press release
Jared Genser, one of the world's most recognized international human rights lawyers, and Lanny J. Davis, an adviser to former presidents George W. Bush and Bill Clinton, join the legal and advocacy team for Cambodian businessman Yim Leak and challenge what they call a coordinated smear campaign in Thailand. International human rights lawyer Jared Genser and Lanny J. Davis, who has close ties to two former US presidents and a worldwide reputation for defending those under attack with lies and smears, and for repairing the damage done to their reputations, have joined the legal and advocacy team supporting Cambodian businessman Yim Leak, Seiden Law LLP, which serves as Yim Leak's chief global counsel, announced today. Their first move is to hold the Thai government accountable, framing its conduct as either complicit in or willfully blind to a sustained smear campaign against Yim. Genser is Managing Director of Perseus Strategies, an international law firm. Over more than two decades, he
Ningbo FEED Meeting Confirms Full Confidence in Q1 2027 FID for Allied Biofuels’ US$6.1 Billion Presidential Decree-Backed SAF and e-SAF Project18.9.2026 17:38:00 CEST | Press release
Allied Biofuels has held a major Front-End Engineering Design (FEED) meeting at Sinopec’s office in Ningbo, China, bringing together Allied Biofuels, Sinopec Engineering Group Co., Ltd. of China, Topsoe A/S of Denmark, Sasol South Africa Limited, and Plug Power of the United States — the principal international engineering and technology providers supporting its US$6.1 billion Presidential Decree-backed Sustainable Aviation Fuel (SAF) and e-SAF project in Uzbekistan. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260918708077/en/ FEED Meeting - Ningbo, China At the joint FEED meeting of the project’s core engineering and technology stakeholders, the discussions established clear alignment on engineering responsibilities, technology interfaces, design deliverables, project integration and the coordinated execution programme required to advance the project through FEED. All stakeholders working on the project expressed full co
Corcept Announces CHMP Opinion Recommending EU Marketing Authorization for Lifyorli® (Relacorilant)18.9.2026 14:00:00 CEST | Press release
Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended that the European Commission (EC) should approve relacorilant, combined with the chemotherapy drug nab-paclitaxel, for the treatment of patients with platinum-resistant ovarian cancer. The CHMP’s recommendation is based on positive data from Corcept’s Phase 2 and pivotal Phase 3 ROSELLA trials, in which patients receiving relacorilant combined with nab-paclitaxel experienced improved progression-free and overall survival compared to patients who received nab-paclitaxel alone. The safety profile of relacorilant plus nab-paclitaxel in these trials was consistent with the safety profile of nab-paclitaxel monoth
Enhertu® Recommended for Approval in the EU by CHMP as Adjuvant Treatment for Patients with Residual Disease After Neoadjuvant Treatment for HER2 Positive Early Breast Cancer18.9.2026 14:00:00 CEST | Press release
Recommendation based on DESTINY-Breast05 phase 3 trial results that showed Enhertu reduced the risk of invasive disease recurrence or death by 53% versus T-DM1 Daiichi Sankyo and AstraZeneca’s Enhertu has the potential to become a new standard of care in this early breast cancer setting Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the adjuvant treatment of adult patients with resected HER2 positive breast cancer who have residual invasive disease after neoadjuvant taxane-based and HER2 targeted treatment. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from the DESTINY-Breast05 phase 3 trial presented at th
CHMP Recommends EU Approval of New Indication for Alfasigma’s Jyseleca® (filgotinib), Treatment of Adults With Axial Spondyloarthritis18.9.2026 12:58:00 CEST | Press release
The information contained within this press release is for the purpose of scientific exchange.It is intended for scientific, financial and investor media only.If approved, Jyselecawill be indicated for the treatment of patients with active axial spondyloarthritis (axSpA), both non-radiographic and radiographic forms of the disease, who have responded inadequately to conventional therapy.Despite the availability of multiple treatment options, nearly half of people living with axSpA do not respond adequately to current therapies, and just 10-20% reach inactive disease within 16-24 weeks of initiating treatment.CHMP’s positive opinion is based on findings from the OLINGUITO Phase 3 study, where improvements in the signs and symptoms of axSpA with filgotinib were observed early and maintained over 52 weeks of treatment.Jyselecais already approved in Europe and the United Kingdom, for the treatment of moderate to severe rheumatoid arthritis and ulcerative colitis. Alfasigma S.p.A, a global
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
